Gene injection aims to restore hearing in deaf children
Disease control
Not yet recruiting
This early-stage trial is testing a new gene therapy injection called EHT102 in children with profound hearing loss caused by specific mutations in the OTOF gene. Up to 30 children will receive a single injection into one ear to see if it is safe and if it can improve their heari…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Euhearing Therapeutics Co., Ltd • Aim: Disease control
Last updated Apr 14, 2026 13:10 UTC